TRIVOLIB 1 (Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg))

TRIVOLIB 1 is a medication commonly used to help manage blood sugar levels in adults with type 2 diabetes. It can support patients in maintaining more stable levels of glucose after meals and throughout the day, promoting better overall health and reducing the risk of complications associated with diabetes.

The active ingredients in TRIVOLIB 1 include Glimepiride, Metformin, and Voglibose. Glimepiride helps the pancreas produce more insulin, which is essential for lowering blood sugar. Metformin works by improving insulin sensitivity and decreasing glucose production in the liver. Voglibose helps to slow down the absorption of carbohydrates from the intestine, contributing to better blood sugar control after eating.

When using TRIVOLIB 1, it is important to store the medication in a cool, dry place away from direct sunlight. Consistent use as directed by a healthcare professional is key to achieving optimal results. It is advisable to monitor blood sugar levels regularly and to maintain a balanced diet and exercise routine.

Some common, mild side effects may include nausea, stomach upset, and mild dizziness. These effects are generally temporary, but if they persist or worsen, it is important to seek advice from a healthcare provider.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.